Molecular Partners AG (MOLN)

Molecular Partners AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	142	165	134	217	631	684
Market Cap Growth	23.05%	23.05%	-38.09%	-65.65%	-7.66%	75.45%
Enterprise Value	-37	10	-106	-67	469	613
Last Close Price	3.97	4.75	4.18	6.55	19.18	-
PE Ratio	-	-	-	1.70	-	-
PS Ratio	25.93	30.11	16.06	1.06	59.00	64.72
PB Ratio	0.91	1.06	0.64	0.85	5.36	5.64
P/TBV Ratio	0.91	1.06	0.64	0.85	5.38	5.66
P/FCF Ratio	-	-	-	1.71	-	-
P/OCF Ratio	-	-	-	1.69	-	-
EV/Sales Ratio	-	1.77	-	-	43.83	58.04
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.06	0.07
Debt / EBITDA Ratio	-	-	-	0.04	-	-
Debt / FCF Ratio	-	-	-	0.04	-	-
Asset Turnover	0.03	0.03	0.03	0.87	0.05	0.06
Quick Ratio	13.96	13.96	13.09	14.53	3.38	3.06
Current Ratio	14.31	14.31	13.35	14.77	3.50	3.08
Return on Equity (ROE)	-33.98%	-33.98%	-30.12%	68.83%	-59.47%	-77.79%
Return on Assets (ROA)	-21.44%	-21.44%	-16.58%	33.52%	-22.01%	-24.93%
Return on Capital (ROIC)	-23.61%	-23.61%	-18.18%	41.25%	-34.80%	-42.60%
Return on Capital Employed (ROCE)	-	-	-	47.60%	-	-
Earnings Yield	-4192.76%	-36.11%	-54.84%	58.79%	-11.09%	-10.38%
FCF Yield	-5149.64%	-40.06%	-52.72%	58.55%	-15.97%	-5.03%
Buyback Yield / Dilution	-385.10%	-3.85%	1.49%	-7.29%	-24.02%	-16.75%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q